Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Enzymaster
company
About
Enzymaster focuses on the development and commercialization of enzymes for the innovative and sustainable production of API intermediates.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥50M
- Industries
- Agriculture,Biopharma,Biotechnology,Chemical
- Founded date
- Dec 5, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥50M
Enzymaster has raised a total of
¥50M
in funding over 2 rounds. Their latest funding was raised on
Sep 30, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 30, 2020 | Series B | ¥50M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Enzymaster is funded by 2 investors.
Leimei Ruisi
and Caozhixing Chuangtou
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Leimei Ruisi
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
